MEXICO CITY (Reuters) -Mexican distiller Becle, better known as the parent company of the popular Jose Cuervo tequila brand, posted a 9.4% increase in first-quarter net profit driven by increased sales, particularly in tequila, the company said in a statement on Thursday.
The U.S. Office of the Comptroller of the Currency (OCC) lifted a 10-year-old consent order with Citigroup Inc, according to an internal memo from the bank viewed by Reuters.
Gilead Sciences Inc on Thursday said its first-quarter revenue rose 3%, helped by sales of HIV drug Biktarvy and COVID antiviral Veklury, but the company reported a net loss as it wrote down the value of its 2020 acquisition of Immunomedics following recent trial results for cancer drug Trodelvy.
Mexican distiller Becle, better known as the parent company of the popular Jose Cuervo tequila brand, posted a 9.4% increase in first-quarter net profit on Thursday, the company said in a statement.
Gilead Sciences Inc on Thursday said its first-quarter revenue rose 3%, helped by increased sales of HIV drug Biktarvy and COVID-19 antiviral drug Veklury.
Wall Street ended sharply higher on Thursday after a strong quarterly report from Meta Platforms lifted beaten down technology and growth stocks and offset worries about the U.S. economy's contraction in the first quarter.
China receives US equipment to make advanced chips despite new rules - report
China receives US equipment to make advanced chips despite new rules-report
U.S. Treasury yields have peaked, say strategists for fourth straight month: Reuters poll
Google's expert in US antitrust trial defends billions paid to device makers
Post-strike Hollywood rushes to get film, TV sets humming
